---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-040337"
form_type: "8-K"
ticker: "SRZN"
cik: "0001824893"
company_name: "Surrozen, Inc./DE"
filed_at: "2024-04-02T23:59:59+00:00"
generated_at: "2026-06-04T03:49:19.570354+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Surrozen raises $17.5M in private placement with milestone-triggered warrants

## Summary
- Issues 1,089,033 shares at $15.50 and pre-funded warrants for 40,000 shares at $15.4999.
- Management purchases 2,948 shares at $16.96; total gross proceeds ~$17.5M.
- Series A warrants: 1,129,033 shares at $15.50, exercisable for 5 years.
- Series B warrants: 1,228,071 shares at $14.25; exercisable after 15-patient enrollment milestone in SZN-043 trial.
- Series C/D warrants: each up to 4,375,000 shares at $16.00, exercisable after Phase 1b data or ≥50 patient enrollment.

## SEC filing metadata
- accession: 0000950170-24-040337
- form_type: 8-K
- ticker: SRZN
- cik: 0001824893
- company_name: Surrozen, Inc./DE
- filed_at: 2024-04-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1824893/000095017024040337/0000950170-24-040337-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1824893/000095017024040337/srzn-20240401.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-040337
- JSON: https://secwatch.observer/filing/0000950170-24-040337.json
- Plain text: https://secwatch.observer/filing/0000950170-24-040337.txt

## Key facts
- Material Agreements
  Surrozen, Inc./DE entered into Securities Purchase Agreement with certain institutional investors and management valued at aggregate gross proceeds of approximately $17.5 million (effective 2024-04-01).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain institutional investors and management
  - Value: aggregate gross proceeds of approximately $17.5 million
  - Effective: 2024-04-01
  source text: On April 1, 2024, Surrozen, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”), with certain institutional investors (the “Investors”) and management (together with the Investors, the “Purchasers”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1824893/000095017024040337/0000950170-24-040337-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.